Inhibrx Biosciences INBX
NASDAQ INBX
$90.61 -1.13 (-1.23%)
At close: Nov 10, 2026 · 4:00 PM EST

Inhibrx Biosciences (INBX) Liabilities and Shareholders Equity (2023 - 2026)

Updated

Analysis

Inhibrx Biosciences (INBX) Liabilities and Shareholders Equity (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 Inhibrx Biosciences 1.33 Bn 760.41 Mn - 154.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.22 Mn
Mar 31, 2026 183.97 Mn
Dec 31, 2025 146.48 Mn
Sep 30, 2025 177.47 Mn
Jun 30, 2025 212.12 Mn
Mar 31, 2025 242.64 Mn
Dec 31, 2024 180.77 Mn
Sep 30, 2024 222.56 Mn
Jun 30, 2024 258.42 Mn
Dec 31, 2023 307.89 Mn
API Access

Inhibrx Biosciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=INBX&period=max&api_key=YOUR_API_KEY